Agent Capital
Overview
Agent Capital is a healthcare venture capital firm focused on investing in novel, differentiated therapeutics and treatments that address unmet patient needs . From preclinical to commercial, they make direct equity investments across all stages of development . The firm aligns with scientists, entrepreneurs, and other investors to develop the next generation of healthcare innovations that will have a positive impact on patients' lives . Their key investment areas include rare diseases, oncology, neurology, and immunology .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Flare Therapeutics | Jun 2026 | Series C | Co-investor |
| Nu-Tek BioSciences | Oct 2025 | Early Funding | Co-investor |
| GlycoEra | May 2025 | Series B | Co-investor |
| Hone Health | Jan 2025 | Series A | Co-investor |
| TRexBio | Nov 2024 | Series B | - |
Key People
Geeta Vemuri
Founder And Managing Partner
Preston Noon
General Partner, Co-Founder
John Glasspool
Venture Partner
John Orloff
Venture Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
